Starling Oncology (STLN) Gross Profit Growth (1y) (2022 - 2026)
Powered by 
Analysis
Starling Oncology (STLN) Gross Profit Growth (1y) (2022 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Profit Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | HCA Healthcare | 90.36 Bn | 89.35 Bn | 15.19 Bn | 2.53% |
| 2 | Tenet Healthcare | 22.02 Bn | 19.85 Bn | 4.45 Bn | 7.27% |
| 3 | Encompass Health | 12.13 Bn | 11.99 Bn | 1.34 Bn | 7.93% |
| 4 | Davita | 11.78 Bn | 11.09 Bn | 1.16 Bn | 3.94% |
| 5 | Universal Health Services | 10.09 Bn | 9.95 Bn | 3.29 Bn | 5.28% |
| 6 | Ensign | 9.97 Bn | 9.65 Bn | 306.24 Mn | 19.63% |
| 7 | Chemed | 6.93 Bn | 6.89 Bn | 221.47 Mn | 19.91% |
| 8 | Pacs | 6.81 Bn | 6.64 Bn | 338.46 Mn | 17.38% |
| 9 | Concentra Group Holdings Parent | 4.32 Bn | 4.16 Bn | 192.10 Mn | 18.98% |
| 10 | Starling Oncology | 609.95 Mn | 568.85 Mn | 27.17 Mn | 55.22% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 55.22% |
| Mar 31, 2026 | 35.17% |
| Dec 31, 2025 | 36.69% |
| Sep 30, 2025 | 31.70% |
| Jun 30, 2025 | -66.38% |
| Mar 31, 2025 | -61.81% |
| Dec 31, 2024 | 346.69% |
| Sep 30, 2024 | -61.25% |
| Jun 30, 2024 | 47.28% |
| Mar 31, 2024 | 35.33% |
| Dec 31, 2023 | 13.26% |
| Sep 30, 2023 | 28.50% |
| Jun 30, 2023 | 26.03% |
| Mar 31, 2023 | 20.14% |
| Dec 31, 2022 | 32.41% |
| Sep 30, 2022 | 7.32% |
| Jun 30, 2022 | 6.76% |
| Mar 31, 2022 | 8.98% |